Altruist Biologics says NMPA accepted LP-003 BLA
Altruist Biologics said China’s NMPA accepted LongBio Pharma’s BLA for LP-003 to treat seasonal allergic rhinitis.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Altruist Biologics said China’s NMPA accepted LongBio Pharma’s BLA for LP-003 to treat seasonal allergic rhinitis.